A Phase 2A, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ES-481 in Adult Patients with Drug Resistant Epilepsy.

  • O'Brien, Terence (Primary Chief Investigator (PCI))
  • Mullen, Saul Alator (Chief Investigator (CI))
  • Nicolo, John-Paul (Chief Investigator (CI))
  • Reutens, David C. (Chief Investigator (CI))

Project: Research

Project Details

Effective start/end date18/01/2118/07/21


  • Neuroscience
  • Epilepsy
  • Clinical trial